Publication: Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Behcet's disease pathogenesis
dc.contributor.coauthor | Gür, Mert | |
dc.contributor.coauthor | Gölcük, Mert | |
dc.contributor.coauthor | Gül, Ahmet | |
dc.contributor.department | Department of Chemical and Biological Engineering | |
dc.contributor.kuauthor | Erman, Burak | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.other | Department of Chemical and Biological Engineering | |
dc.contributor.schoolcollegeinstitute | College of Engineering | |
dc.contributor.yokid | 179997 | |
dc.date.accessioned | 2024-11-10T00:00:28Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Behcet's disease is an inflammatory disorder of unknown etiology. Genetic tendency has an important role in its pathogenesis, and HLA-B51, a class I MHC antigen, has been recognized as the strongest susceptibility factor for Behcet's disease. Despite the confirmation of the association of HLA-B51 with Behcet's disease in different populations, its pathogenic mechanisms remain elusive. HLA-B51 differs in only two amino acids from HLA-B52, other split antigen of HLA-B5, which is not associated with Behcet's disease. These two amino acids are located in the B pocket of the antigen-binding groove, which occupies the second amino acids of the bound peptides. To understand the nature of the HLA-peptide interactions, differences in structure and dynamics of two HLA alleles were investigated by molecular dynamics simulations using YAYDGKDYI, LPRSTVINI, and IPYQDLPHL peptides. For HLA-B51, all bound peptides fluctuated to larger extent than HLA-B52. Free energy profiles of unbinding process for YAYDGKDYI by steered molecular dynamics simulations showed that unbinding from HLA-B52 results in greater free energy differences than HLA-B51. These results suggest the possibility of an instability of HLA-B51 associated with the repertoire of peptides, and this finding may provide significant insight to its pathogenic role in Behcet's disease. | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 1 | |
dc.description.openaccess | NO | |
dc.description.publisherscope | International | |
dc.description.volume | 96 | |
dc.identifier.doi | 10.1111/cbdd.13658 | |
dc.identifier.eissn | 1747-0285 | |
dc.identifier.issn | 1747-0277 | |
dc.identifier.quartile | Q3 | |
dc.identifier.scopus | 2-s2.0-85088278513 | |
dc.identifier.uri | http://dx.doi.org/10.1111/cbdd.13658 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/15803 | |
dc.identifier.wos | 550342600001 | |
dc.language | English | |
dc.source | Chemical Biology and Drug Design | |
dc.subject | Biochemistry | |
dc.subject | Molecular biology | |
dc.title | Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Behcet's disease pathogenesis | |
dc.type | Journal Article | |
dspace.entity.type | Publication | |
local.contributor.authorid | 0000-0002-2496-6059 | |
local.contributor.kuauthor | Erman, Burak | |
relation.isOrgUnitOfPublication | c747a256-6e0c-4969-b1bf-3b9f2f674289 | |
relation.isOrgUnitOfPublication.latestForDiscovery | c747a256-6e0c-4969-b1bf-3b9f2f674289 |